Clinical Kidney Journal
Drug class may be linked to fewer deaths in low-protein kidney disease
Estimated three-year mortality was 14.88% among adults who started renin-angiotensin system inhibitors, versus 18.26% among controls, in an observational study.Estimated three-year mortality was 14.88% among adults who started renin-angiotensin system inhibitors, versus 18.26% among controls, in an observational study.
Cohort · 10,101 peopleKidney
Who was studied10,101 adults with nonproteinuric CKD, three years, against the control group
What changedThree-year all-cause mortality was lower with RASI initiation, 14.88% against 18.26% in the control group
The catchThe abstract does not report drug doses or adverse events